Association of Short-Acting-ß-2 Agonist (SABA) Overuse and Risk of COPD among Adult Asthma Patients

M. Asamoah-Boaheng (St John's, Canada), J. Farrell (St John's, Canada), K. Bonsu (St John's, Canada), W. Midodzi (St John's, Canada)

Source: International Congress 2022 – Chronic airway diseases and infections: management and prevalence

Session: Chronic airway diseases and infections: management and prevalence
Session type: Thematic Poster
Number: 2411

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Asamoah-Boaheng (St John's, Canada), J. Farrell (St John's, Canada), K. Bonsu (St John's, Canada), W. Midodzi (St John's, Canada). Association of Short-Acting-ß-2 Agonist (SABA) Overuse and Risk of COPD among Adult Asthma Patients. 2411

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.